<scp>Multi‐disciplinary</scp> collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with <scp>post‐acute</scp> sequelae of <scp>SARS‐CoV</scp>‐2 infection (<scp>PASC</scp>)

H. Maley, Jason; A. Alba, George; T. Barry, John; N. Bartels, Matthew; K. Fleming, Talya; V. Oleson, Christina; Rydberg, Leslie; Sampsel, Sarah; K. Silver, Julie; Sipes, Sabrina; Verduzco‐Gutierrez, Monica; Wood, Jamie; D. Zibrak, Joseph; Whiteson, Jonathan

doi:10.1002/pmrj.12744

Public

Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post‐acute sequelae of SARS‐CoV‐2 infection (PASC)

Published in PM&R • Dec 13, 2021

Authors:

Jason H. Maley

George A. Alba

John T. Barry

Abstract

Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), may experience lasting sequelae following the acute phase of their index infection.1 The post-acute sequelae of SARS-CoV-2 infection (PASC) can manifest...

Subject

Medicine

Statement (logic)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!